cell therapy

Former Alexion CEO Hallal makes comeback at cell therapy holding firm ElevateBio

https://pharmaphorum.com/news/former-alexion-ceo-hallal-makes-comeback-at-cell-therapy-holding-firm-elevatebio/

Mesoblast poised to file cell therapy for GVHD in US

https://pharmaphorum.com/news/mesoblast-cell-therapy-gvhd-fda/

Cell Mogrify gets £420k funding for regenerative cell therapies

https://pharmaphorum.com/news/cell-mogrify-gets-420k-funding-for-regenerative-cell-therapies/

Will cell and gene therapies disrupt reimbursement?

https://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/will-cell-and-gene-therapies-disrupt-drug-reimbursement/

Nearly 300 gene and cell therapies in development – report

https://pharmaphorum.com/news/nearly-300-gene-and-cell-therapies-in-development-report/

Roche and SQZ expand cell therapy deal to more than $1.3bn

https://pharmaphorum.com/news/roche-and-sqz-expand-cell-therapy-deal-to-more-than-1-3bn/

Gilead signs biotech deal arming T-cells to attack solid tumours

https://pharmaphorum.com/news/gilead-signs-biotech-deal-arming-t-cells-to-attack-solid-tumours/

From Manufacturing to Patient Access: SMi’s Cell & Gene Therapy 2018

https://pharmaphorum.com/partner-content/from-manufacturing-to-patient-access-smis-cell-gene-therapy-2018/

Explore the latest developments in ATMPs at Cell & Gene Therapy 2018

https://pharmaphorum.com/partner-content/explore-the-latest-developments-in-atmps-at-cell-gene-therapy-2018-2/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search